Altiok Doruk, Savci Elif Zeynep, Özkara Büşra, Alkan Kamil, Namdar Dilara Sultan, Tunçer Gizem, Kilinç Buğrahan Regaip, Suiçmez Evren, Çetin Güneysu, Ünal Sinan, Dönmüş Beyza, Karagülleoğlu Zeynep Yağmur, Uncuoğlu Dilruba Beyza, Tekeli Cansu, Mendi Hanife Ayşegül, Bengi Vahdi Umut, Cengiz Seval Güldane, Kiliç Pelin, Güneş Altuntaş Evrim, Demir-Dora Devrim
Faculty of Dentistry, Başkent University, Ankara Turkey.
Turk J Biol. 2021 Aug 30;45(4):404-424. doi: 10.3906/biy-2104-67. eCollection 2021.
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the zoonotic pathogen that causes the "Coronavirus Disease of 2019 (COVID-19)", and COVID-19 itself is yet to be thoroughly understood. Both the disease as well as the mechanisms by which the host interacts with the SARS-CoV-2 have not been fully enlightened. The epidemiological factors -e.g. age, sex, race-, the polymorphisms of the host proteins, the blood types and individual differences have all been in discussions about affecting the progression and the course of COVID-19 both individually and collectively, as their effects are mostly interwoven. We focused mainly on the effect of polymorphic variants of the host proteins that have been shown to take part in and/or affect the pathogenesis of COVID-19. Additionally, how the procedures of diagnosing and treating COVID-19 are affected by these variants and what possible changes can be implemented are the other questions, which are sought to be answered.
新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是导致“2019冠状病毒病(COVID-19)”的人畜共患病原体,而COVID-19本身仍有待深入了解。这种疾病以及宿主与SARS-CoV-2相互作用的机制都尚未完全明晰。流行病学因素,如年龄、性别、种族,宿主蛋白的多态性、血型和个体差异,都在单独或共同影响COVID-19病程和进展的讨论中,因为它们的影响大多相互交织。我们主要关注已被证明参与和/或影响COVID-19发病机制的宿主蛋白多态性变体的作用。此外,这些变体如何影响COVID-19的诊断和治疗程序,以及可以实施哪些可能的改变,是其他有待解答的问题。